1. Home
  2. CBNK vs VALN Comparison

CBNK vs VALN Comparison

Compare CBNK & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBNK

Capital Bancorp Inc.

HOLD

Current Price

$33.32

Market Cap

519.9M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.36

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBNK
VALN
Founded
1974
2012
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
519.9M
536.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
CBNK
VALN
Price
$33.32
$5.36
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$35.50
$15.50
AVG Volume (30 Days)
62.6K
26.0K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
1.52%
N/A
EPS Growth
60.85
N/A
EPS
0.73
N/A
Revenue
N/A
N/A
Revenue This Year
$16.20
N/A
Revenue Next Year
$8.52
$93.87
P/E Ratio
$45.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.40
$5.06
52 Week High
$36.40
$12.25

Technical Indicators

Market Signals
Indicator
CBNK
VALN
Relative Strength Index (RSI) 59.22 40.34
Support Level $30.00 $5.11
Resistance Level $33.50 $6.69
Average True Range (ATR) 0.97 0.19
MACD 0.04 -0.01
Stochastic Oscillator 63.31 25.53

Price Performance

Historical Comparison
CBNK
VALN

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage. The company generates majority revenue from the Commercial bank sector. Commercial Banking division focuses on providing personalized service to commercial clients throughout the operations supplemented by lending outside primary market as well as engaging in government guaranteed lending on a national basis.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: